{"title":"乳腺癌高危妇女的筛查策略:文献综述","authors":"Caren González Rojas , Ana Karina Gordillo Ledesma , Víctor Arturo Acosta Marín","doi":"10.1016/j.senol.2024.100594","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Breast cancer is the most common cancer diagnosed in the female population in the world, but not all women have the same absolute lifetime risk of developing it, there being a group called “high risk” with a risk equal to or greater than 20%, in whom the disease begins at an earlier age and tends to be more aggressive.</p></div><div><h3>Materials and methods</h3><p>A review of the literature was carried out in Google Scholar and PubMed databases using keywords such as “breast cancer”, “high risk”, “breast cancer induced by radiotherapy”, “screening”, “protocols”, and “images”. Finally, 53 articles were analyzed, after applying the inclusion and exclusion criteria.</p></div><div><h3>Results</h3><p>All women should undergo a risk assessment starting at 25 years of age. In the high-risk group, the screening strategy should be early, multimodal and annual. Ample evidence in the literature that MRI is the most sensitive imaging method for the diagnostic of breast cancer.</p></div><div><h3>Conclusion</h3><p>Breast MRI will be the method of choice along with mammography to perform annual screening in this risk group. The heterogeneity of the subgroups within this high-risk group and the advent of AI improving the precision of diagnostic methods raises the need to personalize screening strategies.</p></div>","PeriodicalId":38058,"journal":{"name":"Revista de Senologia y Patologia Mamaria","volume":"37 3","pages":"Article 100594"},"PeriodicalIF":0.2000,"publicationDate":"2024-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Estrategias de pesquisa en mujeres de alto riesgo para cáncer de mama: revisión de la literatura\",\"authors\":\"Caren González Rojas , Ana Karina Gordillo Ledesma , Víctor Arturo Acosta Marín\",\"doi\":\"10.1016/j.senol.2024.100594\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><p>Breast cancer is the most common cancer diagnosed in the female population in the world, but not all women have the same absolute lifetime risk of developing it, there being a group called “high risk” with a risk equal to or greater than 20%, in whom the disease begins at an earlier age and tends to be more aggressive.</p></div><div><h3>Materials and methods</h3><p>A review of the literature was carried out in Google Scholar and PubMed databases using keywords such as “breast cancer”, “high risk”, “breast cancer induced by radiotherapy”, “screening”, “protocols”, and “images”. Finally, 53 articles were analyzed, after applying the inclusion and exclusion criteria.</p></div><div><h3>Results</h3><p>All women should undergo a risk assessment starting at 25 years of age. In the high-risk group, the screening strategy should be early, multimodal and annual. Ample evidence in the literature that MRI is the most sensitive imaging method for the diagnostic of breast cancer.</p></div><div><h3>Conclusion</h3><p>Breast MRI will be the method of choice along with mammography to perform annual screening in this risk group. The heterogeneity of the subgroups within this high-risk group and the advent of AI improving the precision of diagnostic methods raises the need to personalize screening strategies.</p></div>\",\"PeriodicalId\":38058,\"journal\":{\"name\":\"Revista de Senologia y Patologia Mamaria\",\"volume\":\"37 3\",\"pages\":\"Article 100594\"},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2024-04-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista de Senologia y Patologia Mamaria\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0214158224000227\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista de Senologia y Patologia Mamaria","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0214158224000227","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
导言乳腺癌是世界上女性人群中最常见的癌症,但并非所有女性一生中患乳腺癌的绝对风险都相同,有一个群体被称为 "高风险",其风险等于或大于 20%,她们的发病年龄较早,而且往往更具侵袭性。材料和方法在 Google Scholar 和 PubMed 数据库中使用 "乳腺癌"、"高风险"、"放疗诱发的乳腺癌"、"筛查"、"方案 "和 "图像 "等关键词对文献进行了综述。结果 所有女性都应从 25 岁开始接受风险评估。对于高危人群,筛查策略应是早期、多模式和每年一次。文献中有大量证据表明,磁共振成像是诊断乳腺癌最灵敏的成像方法。结论乳腺磁共振成像将与乳房 X 线照相术一起成为该高危人群进行年度筛查的首选方法。这一高风险群体中的亚组具有异质性,而人工智能的出现又提高了诊断方法的精确性,因此有必要制定个性化的筛查策略。
Estrategias de pesquisa en mujeres de alto riesgo para cáncer de mama: revisión de la literatura
Introduction
Breast cancer is the most common cancer diagnosed in the female population in the world, but not all women have the same absolute lifetime risk of developing it, there being a group called “high risk” with a risk equal to or greater than 20%, in whom the disease begins at an earlier age and tends to be more aggressive.
Materials and methods
A review of the literature was carried out in Google Scholar and PubMed databases using keywords such as “breast cancer”, “high risk”, “breast cancer induced by radiotherapy”, “screening”, “protocols”, and “images”. Finally, 53 articles were analyzed, after applying the inclusion and exclusion criteria.
Results
All women should undergo a risk assessment starting at 25 years of age. In the high-risk group, the screening strategy should be early, multimodal and annual. Ample evidence in the literature that MRI is the most sensitive imaging method for the diagnostic of breast cancer.
Conclusion
Breast MRI will be the method of choice along with mammography to perform annual screening in this risk group. The heterogeneity of the subgroups within this high-risk group and the advent of AI improving the precision of diagnostic methods raises the need to personalize screening strategies.